Carregant...
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk
(Hydroxy)chloroquine ((H)CQ) is being investigated as a treatment for COVID-19, but studies have so far demonstrated either no or a small benefit. However, these studies have been mostly performed in patients admitted to the hospital and hence likely already (severely) affected. Another suggested ap...
Guardat en:
| Publicat a: | Heart Rhythm |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Authors. Published by Elsevier Inc. on behalf of Heart Rhythm Society.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7332460/ https://ncbi.nlm.nih.gov/pubmed/32622993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hrthm.2020.07.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|